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Summary
Osteoarthritis of the trapeziometarcarpal joint, also called
rhizarthrosis, is a common finding in the second half of life.
It has a higher prevalence in females and is of growing im-
portance in ageing societies. A variety of conservative and
surgical treatment options are known, including conserva-
tive treatment up to joint replacement. Without treatment,
rhizarthrosis can lead to disabling pain and loss of hand
function. The goal of this overview of treatment options is
to present a stepwise approach that can be initiated by
any physician.
Treatment of trapeziometacarpal osteoarthritis should be
started early with conservative measures such as splinting
and physical therapy, which can be supplemented by oral
and topical analgesics and local infiltrations subsequently.
If all of these interventions do not provide sufficient relief,
referral to a hand surgeon should be considered.
Surgical strategies vary from arthroscopic debridement
over trapeziectomy, with or without tendon interposition
and ligament reconstruction, to interposition implants and
total joint replacements. The planned intervention should
be based on clinical and subjective functional limitations
and associated degenerative changes, as well as the pa-
tient’s expectations and needs.
The goal of this paper is to develop a treatment algorithm,
leading to higher levels of patient functionality and satis-
faction. Below we discuss the current literature and point
out key treatment options used in our department.
Introduction
Osteoarthritis of the trapeziometarcarpal joint (TMO) is a
common disease, especially in postmenopausal women [1,
2]. Radiological prevalence ranges from 13.4% above 70
years of age up to 35.8% above 55 years [3]. However, ra-
diographic findings do not always correlate with clinical
symptoms [4]. The prevalence of symptomatic TMO is no-
tably lower than radiological changes, which are often in-
cidental [5]. Symptomatic TMO has been found to peak
at 5.3% in women aged 70–74 and at 1.7% in men aged
80–84 [6]. On the other hand, there is often no or little evi-
dence of TMO on conventional radiographs in early stages,
whereas functional limitations and pain can be very promi-
nent [5]. Symptoms of TMO usually include pain in the
trapeziometarcarpal (TMC) joint, reduced hand strength
and decreased mobility of the thumb [7]. Pain can vary
from episodic to pain related to a specific activity, some-
times accompanied by a background ache [7, 8]. Grasping
and pinching is often limited [9]. As the thumb is needed
for countless daily activities and represents approximately
40% of overall hand function, limitation of its function can
be very disabling [9–11]. Known risk factors include obe-
sity [5], heavy manual labour [12], female gender and hor-
monal changes, such as menopause [1]. Trauma, rheuma-
toid arthritis and hyperlaxity diseases (Marfan/
Ehlers-Danlos) are risk factors for secondary osteoarthritis
of the TMC joint [13, 14]. Because of our ageing societies,
TMO is a growing medical challenge and economic burden
[15]. Patients who are referred to our hand surgical consul-
tation are mostly aware of their diagnosis, but have not yet
received the full array of conservative treatments and often
hesitate to consider surgical treatment. This review aims to
give an overview of current and evidence-based treatment




In 1987, Eaton and Littler proposed a radiological classi-
fication of trapeziometacarpal osteoarthritis, which is still
the most widely used for staging. This classification sys-
tem consists of four different stages (fig. 1) [16, 17]. Even
though other imaging techniques and classification sys-
tems exist, X-rays of the thumb in two planes remain the
gold standard and should be ordered early in suspected
TMO [16, 17]. It is, however, important to evaluate the
neighbouring joints such as the scaphotrapezial and
scaphotrapezoidal (STT) joints for treatment.
Additional imaging
Multilayer imaging can help to evaluate the
trapeziometacarpal joint and the neighbouring joints in
more detail. To evaluate bone stock and cartilage surfaces,
and especially if planning prosthetic implants, computed
tomography (CT) enhanced by intra-articular contrast in-
jection can be useful [18]. Magnetic resonance imaging
(MRI) allows ligament and soft tissue evaluation. Recent
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developments of specific sequences can quantitatively
analyse cartilage or define alterations in its composition
[19]. Single-photon emission computed tomography com-
bined with conventional CT (SPECT/CT) can be used to
discriminate between pain arising from the TMC or the
STT joint [20]. In patients with persistent postoperative
pain SPECT is a good adjunct, as other forms of imaging
can be difficult to evaluate owing to residual changes from
the intervention [21]. Arthroscopic evaluation may allow
earlier and more detailed evaluation of degenerative
changes [22].
The treatment ladder
Treatment of TMO should not only be based on the radio-
logical classification, but also focus on the patient’s symp-
toms, subjective loss of function and the evolution over
time. Conservative options are at the bottom and ultimate-
ly surgery is the last step of the treatment ladder (fig. 2).
The treatment ladder is based on current literature, as well
as experience in our centre.
Step I: Multimodal conservative treatment
In every stage of TMO, conservative treatment is the first
step of the treatment ladder. All therapeutic modalities de-
scribed below should be used in combination to optimise
the treatment effect.
Figure 1: Eaton/Littler classification of trapeziometacarpal osteoarthritis.Stage I: slight widening of the joint space and normal contours.Stage
II: slight narrowing of the TMC and sclerosis, osteophytes <2mm, up to 1/3 subluxation of the jointStage III: marked joint space narrowing, os-
teophytes >2mm, >1/3 subluxationStage IV: Pantrapezial arthritis, major subluxation, cystic and sclerotic subchondral bone changes, signifi-
cant erosion of the scaphotrapezial joint.
Figure 2: Treatment ladder for basal thumb osteoarthritis. A structured approach for all caregivers recommended by the department of hand
surgery at Inselspital Bern, Switzerland. Different steps should be combined to ensure optimal treatment. If results are unsatisfactory for the
patient, the treatment can be escalated to the next step.
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Splinting
In a recent meta-analysis, splinting caused a moderate to
large reduction in pain in the medium term (3–12 months)
and an improvement of function, and can avoid surgical
treatment in some patients [23, 24]
In our experience, neoprene bandages provide a high level
of comfort for the patients with low risk of developing
pressure points, at low cost. Additionally, they serve as
an insulation layer, which may help to reduce cold-related
worsening of symptoms (fig. 3a). For some patients, taping
may present a good alternative (fig. 3b) [25]. For those
more comfortable with a rigid support, a thermomoulded
splint can be an option (fig. 3c).
Physical therapy
Physical therapy by specialised hand therapists leads to a
significant improvement in pain and hand function [26].
Specific hand exercises help to increase grip strength and
function, reduce pain and improve the range of movement
of the thumb [27]. Some investigators focus primarily on
increasing the range of movement and strengthening intrin-
sic and extrinsic muscles by providing a set of exercises
that are based on biomechanical findings in cadaver studies
[28]. Others prefer the so-called dynamic stability mod-
elled approach, including a variety of hand exercises that
focus on restoration of the thumb web space, re-education
of thumb muscles, joint mobilisation and muscle strength-
ening, which has been able to show significant reduction in
pain and disability [29].
We therefore recommend initiating physical therapy, to-
gether with splinting, as one of the first steps in treating
TMO [30].
Step 2: Pharmacological therapy
The American College of Rheumatology in 2012 and the
European League against Rheumatism recommended the
use of one or more of the following drugs for patients suf-
fering from hand osteoarthritis [31, 32]:
– Topical capsaicin
– Topical nonsteroidal anti-inflammatory drugs
(NSAIDs)
– Oral NSAIDs, including cyclo-oxygenase-2 (COX2)-
selective inhibitors
– Oral chondroitin sulphate
In patients older than 75 years, topical use of NSAIDs is
preferred, as side effects might outweigh the benefits of
systemic application, especially when used over a longer
period of time [31–33]. There is no evidence on superiority
of one specific anti-inflammatory treatment over another in
TMO [31, 32]. In addition, topical capsaicin has been de-
scribed as an option to reduce tenderness and pain [34, 35].
Oral chondroitin sulphate has shown effectiveness in re-
lieving symptoms of hand osteoarthritis [36]. As side ef-
fects are rare and benign, we recommend its use.
Paracetamol is regularly prescribed for patients suffering
from hand osteoarthritis with contraindications for NSAID
use [31]. However, in three small trials, paracetamol
showed no superiority over placebo or an active compara-
tor [31, 37–39].
Therefore, as an add-on therapy to step 1, we recommend
analgesics for short-term use, if applied orally. If all con-
servative treatments fail, treatment can be escalated to
more invasive approaches.
Step 3: Infiltration therapy
Corticosteroid injections into the TMC joint can provide
short-term benefits, with pain relief and improved function
[40]. Unfortunately, the effect usually does not last longer
than 1–3 months [40–42]. Nevertheless, in early stages
of TMO or when inflammation is predominant corticos-
Figure 3: Different splints of the TMC joint. The right splint has to be chosen according to the patient’s needs and demands. Neoprene ban-
dages (a) provide a high level of comfort and serve as insulation layer. Taping (b) presents a good alternative, especially for those needing to
wear gloves at work (e.g., healthcare professionals). Rigid individual splints (c) provide the highest level of stability.
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teroids infiltration, in combination with splinting, can pro-
vide long-term pain relief [43]. It remains unclear whether
the volume injected into the joint or specific anti-inflam-
matory effects are responsible for pain reduction, as some
studies have revealed that saline injections can provide
similar results [9, 42].
Hyaluronic acid or dextrose injections present alternatives
for injection therapy [44] and autologous fat transfer (stem
cells) was suggested as an interesting alternative [45]. Nev-
ertheless, only steroid injections are reimbursed by insur-
ance companies in Switzerland. Complications and mor-
bidity of injections are generally low. In a recent
systematic review and meta-analysis, no adverse effects,
such as intra-articular infections, were found in the studies
included [44]. On the other hand, the evidence for long-
term benefits was considered low, so that injections remain
a topic of discussion [44].
If pain relief is provided effectively by the first steroid in-
jection, we recommend up to three injections with a delay
of 3 months before escalating to a surgical intervention.
Step 4: Surgical interventions
Several surgical interventions exist for the treatment of
TMO, but none has been shown to be ultimately superior
[46]. We will shortly describe the different options and
their indications hereafter.
Trapeziectomy with or without ligament reconstruction
and interposition
Resection arthroplasty consists of surgical removal of the
trapezium bone and can be combined with ligament recon-
struction and interposition (LRTI).
The latter adds suspension with a tendon strip in order
to support the first metacarpal bone, as well as filling
the trapezial space with the partially resected local tendon
(fig. 4) [47]. Both interventions show equal long-term out-
comes, nevertheless simple trapeziectomy is a shorter pro-
cedure with slightly lower complication rates [48–51].
Nevertheless, most hand surgeons prefer LRTI to simple
trapeziectomy [52] and it thus represents the most common
surgical therapy for patients suffering from advanced
stages of TMO [6]. A possible explanation could be that
the ligament reconstruction allows initial suspension and
early functional rehabilitation. Ligament reconstruction
and interposition using artificial material or allografts have
fallen out of favour due to significantly higher complica-
tion rates [53].
Shortcomings of both techniques are the risk of subsidence
of the first ray and decreased strength and mobility [54].
Although studies show no correlation between success of
LRTI and radiologic subsidence [55–57], a conflict be-
tween the scaphoid and the base of the metacarpal I can be
a reason for persistence or recurrent pain. Especially in ad-
vanced TMO, when the scaphotrapeziotrapezoidal (STT)
joint is involved, partial trapezial excision has been shown
to exacerbate pre-existing positional abnormalities and de-
generative changes of the carpus [52, 58]. Other options
should be considered in these situations.
Joint replacement surgery
Alternatives consist of a wide variety of interpositional
prosthetic implants, whose use has been increasing in the
last decades [59]. In the early days, loosening presented
the main complication of the different subtypes, with rates
ranging from 3% up to 53% [60–62]. Most prosthetic im-
plants changed continuously over time, so that long-term
outcomes mainly exist for models not being used anymore
because of high complication rates. On the other hand,
some studies report better postoperative pinch strength,
greater reduction in metacarpophalangeal (MCP) joint hy-
perextension and faster recovery for patients treated with a
prosthesis [63–65]. Non-cemented prostheses provide bet-
ter results in mid-term follow-up [66, 67], high rates of pa-
tient satisfaction and 71–92% survival rates in a 10-year
follow-up [68, 69]. There is a lack of prospective studies
directly comparing trapeziectomy with the different pros-
theses [59], but at present overall prosthetic implants seem
to have a higher complication rate and inferior long-term
outcomes compared with resection arthroplasty [69, 70].
There are several other treatment options, but for an
overview we focus on the procedures and techniques used
in the department of hand surgery at Inselspital (Bern,
Switzerland). Thus, one model representative of a total
joint replacement prosthesis (Touch®), one surface replace-
ment implant (Pyrocardan®) and the surgical technique of
arthrodesis are described below.
Total joint replacement prosthesis
The Touch® prosthesis (KeriMedical, Geneva, Switzer-
land) has been introduced onto the market as a dual mobili-
ty trapeziometarcarpal prosthesis. A first case series of 132
patients showed a reduction of luxations and a longer lifes-
pan compared with older prosthesis [71]. Because of faster
Figure 4: Left thumb after trapeziectomy with ligament reconstruc-
tion and tendon interposition. Lateral view (left) and anterior-poste-
rior view (right). After complete resection of the trapezial bone, the
height of the thumb is preserved by filling the trapezial space with
the partially resected flexor carpi radialis tendon. This resection-
tendon-interposition and suspension arthroplasty is used by many
hand surgeons.
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rehabilitation and preservation of length in the first ray,
this possibility can be considered especially for younger
patients and if fine motor skills are needed. However, as
long-term data for this prosthesis are not yet available, the
pros and cons should be discussed in detail with the pa-
tient. At this point, there is a need for high-quality ran-
domised studies to investigate whether it is able to deliver
superior long-term results [72].
Spacer
Pyrocarbon has a module of elasticity similar to that of
cortical bone and is therefore well suited for interposition
arthroplasties [73]. There are several implant models for
different joints. The Pyrocardan® spacer is a hyperbolic pa-
raboloid disk, which is inserted into the joint after partial
resection of the first metacarpal and the trapezium bone
(fig. 5). Five-year survival rates of 90% were reported [74].
In several studies, the Pyrocardan® spacer had similar out-
comes to conventional arthroplasties, but shorter postoper-
ative rehabilitation until relief of symptoms [75, 76]. Re-
vision rates in several studies vary from 3.2% after 60
months of follow up to 25% after 26 months [75, 77].
The main benefit of using an interposition arthroplasty is
the maintenance of length of the first ray. Furthermore, it
can easily be revised by a trapeziectomy with or without
LRTI in the case of failure [78, 79]. Pyrocardan® implants
can also be used as a double arthroplasty in the TMC
and STT joints in patients with stage IV osteoarthritis, or
as an interposition spacer after failed trapeziectomy with
subsidence [80]. As for the other prosthetic implants, no
prospective long-term data proving its superiority to sim-
ple trapeziectomy are available and thus the potential ad-
vantages have to be outweighed with the complication rate
and higher cost.
Figure 5: Implantation of a Pyrocardan® spacer in the left thumb.
Before (left) and after (right) implantation of Pyrocardan®. After
partial resection of the trapezial and first metacarpal bone, the
spacer of pyrocarbon is interposed in the joint.
Arthrodesis
Lastly, arthrodesis may be a primary or a salvage option
for TMO [81]. Arthrodesis as a treatment option for TMO
is reserved for a limited subgroup of patients, as it fixes
the position of the thumb in physiological antepulsion.
However, the length of the first ray is better preserved
with more force due to the proximal stability on the cost
of motion. Arthrodesis has been shown to have relatively
high rates of non-union, especially with earlier bone fix-
ation techniques and it may lead to further progression
of STT arthrosis [82–84]. In one study, an increased grip
strength following arthrodesis as compared with trapeziec-
tomy with LRTI has been described [50]. In our opinion,
arthrodesis is therefore only indicated in exceptional cases
such as young manual workers or complex revision cases.
Overview
In our ageing society, osteoarthrosis of the
trapeziometacarpal joint represents a common disease of
growing importance. The challenge to enable good access
to optimised treatment options requires a stepwise ap-
proach. The growing number of patients suffering from
TMO demands standardised treatment schemes applicable
not only by hand surgeons.
Following clinical examination and conventional x-rays,
to ensure the right diagnosis, we therefore recommend the
subsequent stepwise approach for all caregivers involved
in the patient’s care:
Step 1: Multimodal conservative treatment, including edu-
cation, physical therapy and splinting. Specific hand ther-
apy may apply physical anti-inflammatory and analgesic
treatments, as well as instruct correct use of the weakened
thumb.
Step 2: Pharmacological therapy, which involves chon-
droitin sulphate, topical capsaicin, short-term treatment
with oral NSAIDs. For all pharmacological treatments, the
individual patient’s risk factors need to be respected to
ensure the right risk-benefit-ratio. In addition, oral chon-
droitin sulphate has been investigated and might present an
alternative in the future.
Step 3: Infiltration therapy of the TMC joint, using
steroids, hyaluronic acid, dextrose or saline showed con-
tradictory results in the latest studies. They might offer a
treatment option, as the rate of adverse effects is very low.
Also, infiltration therapy showed a potential to postpone
surgery. We recommend only cortisone infiltration, as it is
the only product accepted by insurance companies.
Step 4: Surgical interventions are indicated, if all conserva-
tive treatment options fail and symptoms lead to unaccept-
ably diminished function for the patient.
Many different surgical options exist. Currently, simple
trapeziectomy or trapeziectomy with LRTI present com-
parable options with no significant differences in long-
term results. Newer therapies, such as total joint or surface
replacement using implants were able to show faster re-
habilitation time, but often less convincing long-term re-
sults. For many newer types of prosthesis, long-term fol-
low-up data are still lacking. Therefore, they should only
be discussed with caution in young patients with high de-
mands. In the case of an unfavourable outcome, secondary
trapeziectomy presents a surgical option.
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Steps 1–3 can easily be taken by general practitioners,
rheumatologists, orthopaedic surgeons and other col-
leagues caring for TMO patients and do not require im-
mediate consultation of a hand surgeon. These steps have
been shown to avoid or postpone more invasive treatments,
while reducing the patient’s symptoms.
If these measures fail over a period of at least 3 months, we
recommend discussing referral to a hand surgeon to evalu-
ate the patient’s needs and will for surgery.
This review of current state-of-the-art therapies aims to
emphasise that coordinated and combined use of different
treatment options has a higher chance to lead to long-term
patient satisfaction and might postpone or prevent surgery.
Disclosure statement
No financial support and no other potential conflict of interest relevant
to this article was reported.
References
1 Armstrong AL, Hunter JB, Davis TR. The prevalence of degenerative
arthritis of the base of the thumb in post-menopausal women. J Hand
Surg [Br]. 1994;19(3):340–1. doi: http://dx.doi.org/10.1016/
0266-7681(94)90085-X. PubMed.
2 Swigart CR, Eaton RG, Glickel SZ, Johnson C. Splinting in the treat-
ment of arthritis of the first carpometacarpal joint. J Hand Surg Am.
1999;24(1):86–91. doi: http://dx.doi.org/10.1053/jhsu.1999.jh-
su24a0086. PubMed.
3 National Institute for Health and Clinical Excellence. Guidance. Os-
teoarthritis: Care and Management in Adults. London: NICE; 2014.
4 Botha-Scheepers S, Riyazi N, Watt I, Rosendaal FR, Slagboom E, Bel-
lamy N, et al. Progression of hand osteoarthritis over 2 years: a clinical
and radiological follow-up study. Ann Rheum Dis. 2009;68(8):1260–4.
doi: http://dx.doi.org/10.1136/ard.2008.087981. PubMed.
5 Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, Pols HA, Hazes JM, Koes
BW. Prevalence and pattern of radiographic hand osteoarthritis and as-
sociation with pain and disability (the Rotterdam study). Ann Rheum
Dis. 2005;64(5):682–7. doi: http://dx.doi.org/10.1136/ard.2004.023564.
PubMed.
6 Wolf JM, Delaronde S. Current trends in nonoperative and operative
treatment of trapeziometacarpal osteoarthritis: a survey of US hand sur-
geons. J Hand Surg Am. 2012;37(1):77–82. doi: http://dx.doi.org/
10.1016/j.jhsa.2011.10.010. PubMed.
7 Wilkens SC, Meghpara MM, Ring D, Coert JH, Jupiter JB, Chen NC.
Trapeziometacarpal Arthrosis. JBJS Rev. 2019;7(1):e8. doi:
http://dx.doi.org/10.2106/JBJS.RVW.18.00020. PubMed.
8 McQuillan TJ, Kenney D, Crisco JJ, Weiss AP, Ladd AL. Weaker Func-
tional Pinch Strength Is Associated With Early Thumb Carpometacarpal
Osteoarthritis. Clin Orthop Relat Res. 2016;474(2):557–61. doi:
http://dx.doi.org/10.1007/s11999-015-4599-9. PubMed.
9 Hamasaki T, Laprise S, Harris PG, Bureau NJ, Gaudreault N, Ziegler D,
et al. Efficacy of non-surgical interventions for trapeziometacarpal
(thumb base) osteoarthritis: A systematic review. Arthritis Care Res
(Hoboken). 2020;72(12):1719–35. doi: http://dx.doi.org/10.1002/
acr.24084. PubMed.
10 Ladd AL, Weiss AP, Crisco JJ, Hagert E, Wolf JM, Glickel SZ, et al.
The thumb carpometacarpal joint: anatomy, hormones, and biomechan-
ics. Instr Course Lect. 2013;62:165–79. PubMed.
11 Berger AJ, Meals RA. Management of osteoarthrosis of the thumb
joints. J Hand Surg Am. 2015;40(4):843–50. doi: http://dx.doi.org/
10.1016/j.jhsa.2014.11.026. PubMed.
12 Jensen JC, Sherson D. Work-related bilateral osteoarthritis of the first
carpometacarpal joints. Occup Med (Lond). 2007;57(6):456–60. doi:
http://dx.doi.org/10.1093/occmed/kqm029. PubMed.
13 Wolf JM, Schreier S, Tomsick S, Williams A, Petersen B. Radiographic
laxity of the trapeziometacarpal joint is correlated with generalized joint
hypermobility. J Hand Surg Am. 2011;36(7):1165–9. doi:
http://dx.doi.org/10.1016/j.jhsa.2011.03.017. PubMed.
14 Jónsson H, Valtýsdóttir ST, Kjartansson O, Brekkan A. Hypermobility
associated with osteoarthritis of the thumb base: a clinical and radiologi-
cal subset of hand osteoarthritis. Ann Rheum Dis. 1996;55(8):540–3.
doi: http://dx.doi.org/10.1136/ard.55.8.540. PubMed.
15 Hamasaki T, Lalonde L, Harris P, Bureau NJ, Gaudreault N, Ziegler D,
et al. Efficacy of treatments and pain management for
trapeziometacarpal (thumb base) osteoarthritis: protocol for a systematic
review. BMJ Open. 2015;5(10):e008904. doi: http://dx.doi.org/10.1136/
bmjopen-2015-008904. PubMed.
16 Eaton RG, Glickel SZ. Trapeziometacarpal osteoarthritis. Staging as a
rationale for treatment. Hand Clin. 1987;3(4):455–71. PubMed.
17 Kennedy CD, Manske MC, Huang JI. Classifications in Brief: The
Eaton-Littler Classification of Thumb Carpometacarpal Joint Arthrosis.
Clin Orthop Relat Res. 2016;474(12):2729–33. doi: http://dx.doi.org/
10.1007/s11999-016-4864-6. PubMed.
18 Cernohorsky P, Strackee SD, Streekstra GJ, van den Wijngaard JP,
Spaan JAE, Siebes M, et al. Computed Tomography-Mediated Registra-
tion of Trapeziometacarpal Articular Cartilage Using Intraarticular Opti-
cal Coherence Tomography and Cryomicrotome Imaging: A Cadaver
Study. Cartilage. 2019:1947603519860247. doi: http://dx.doi.org/
10.1177/1947603519860247. PubMed.
19 Hayashi D, Roemer FW, Guermazi A. Imaging of osteoarthritis-recent
research developments and future perspective. Br J Radiol.
2018;91(1085):20170349. doi: http://dx.doi.org/10.1259/bjr.20170349.
PubMed.
20 van Rijn SF, de Vries MR, Kraan GA. The use of single photon emis-
sion computed tomography/computed tomography to differentiate be-
tween pain arising from trapeziometacarpal joint and scaphotrapezio-
trapezoid joint osteoarthritis. J Hand Surg Eur Vol. 2016;41(7):776–7.
doi: http://dx.doi.org/10.1177/1753193415606070. PubMed.
21 Strobel K, van der Bruggen W, Hug U, Gnanasegaran G, Kampen WU,
Kuwert T, et al. SPECT/CT in Postoperative Hand and Wrist Pain.
Semin Nucl Med. 2018;48(5):396–409. doi: http://dx.doi.org/10.1053/
j.semnuclmed.2018.05.001. PubMed.
22 Badia A. Trapeziometacarpal arthroscopy: a classification and treatment
algorithm. Hand Clin. 2006;22(2):153–63. doi: http://dx.doi.org/
10.1016/j.hcl.2006.02.006. PubMed.
23 Buhler M, Chapple CM, Stebbings S, Sangelaji B, Baxter GD. Effec-
tiveness of splinting for pain and function in people with thumb car-
pometacarpal osteoarthritis: a systematic review with meta-analysis. Os-
teoarthritis Cartilage. 2019;27(4):547–59. doi: http://dx.doi.org/10.1016/
j.joca.2018.09.012. PubMed.
24 Valdes K, Marik T. A systematic review of conservative interventions
for osteoarthritis of the hand. J Hand Ther. 2010;23(4):334–50, quiz
351. doi: http://dx.doi.org/10.1016/j.jht.2010.05.001. PubMed.
25 Villafañe JH, Langford D, Alguacil-Diego IM, Fernández-Carnero J.
Management of trapeziometacarpal osteoarthritis pain and dysfunction
using mobilization with movement technique in combination with kine-
siology tape: a case report. J Chiropr Med. 2013;12(2):79–86. doi:
http://dx.doi.org/10.1016/j.jcm.2013.06.001. PubMed.
26 Ahern M, Skyllas J, Wajon A, Hush J. The effectiveness of physical
therapies for patients with base of thumb osteoarthritis: Systematic re-
view and meta-analysis. Musculoskelet Sci Pract. 2018;35:46–54. doi:
http://dx.doi.org/10.1016/j.msksp.2018.02.005. PubMed.
27 Spaans AJ, van Minnen LP, Kon M, Schuurman AH, Schreuders AR,
Vermeulen GM. Conservative treatment of thumb base osteoarthritis: a
systematic review. J Hand Surg Am. 2015;40(1):16–21.e6. doi:
http://dx.doi.org/10.1016/j.jhsa.2014.08.047. PubMed.
28 Valdes K, von der Heyde R. An exercise program for carpometacarpal
osteoarthritis based on biomechanical principles. J Hand Ther.
2012;25(3):251–62, quiz 263. doi: http://dx.doi.org/10.1016/
j.jht.2012.03.008. PubMed.
29 O’Brien VH, Giveans MR. Effects of a dynamic stability approach in
conservative intervention of the carpometacarpal joint of the thumb: a
retrospective study. J Hand Ther. 2013;26(1):44–51, quiz 52. doi:
http://dx.doi.org/10.1016/j.jht.2012.10.005. PubMed.
30 Østerås N, Kjeken I, Smedslund G, Moe RH, Slatkowsky-Christensen
B, Uhlig T, et al. Exercise for Hand Osteoarthritis: A Cochrane System-
atic Review. J Rheumatol. 2017;44(12):1850–8. doi: http://dx.doi.org/
10.3899/jrheum.170424. PubMed.
31 Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS,
Greibrokk E, et al. 2018 update of the EULAR recommendations for the
management of hand osteoarthritis. Ann Rheum Dis. 2019;78(1):16–24.
doi: http://dx.doi.org/10.1136/annrheumdis-2018-213826. PubMed.
32 Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, Mc-
Gowan J, et al.; American College of Rheumatology. American College
of Rheumatology 2012 recommendations for the use of nonpharmaco-
logic and pharmacologic therapies in osteoarthritis of the hand, hip, and
knee. Arthritis Care Res (Hoboken). 2012;64(4):465–74. doi:
http://dx.doi.org/10.1002/acr.21596. PubMed.
33 Pelletier JP, Martel-Pelletier J, Rannou F, Cooper C. Efficacy and safety
of oral NSAIDs and analgesics in the management of osteoarthritis: Evi-
dence from real-life setting trials and surveys. Semin Arthritis Rheum.
2016;45(4, Suppl):S22–7. doi: http://dx.doi.org/10.1016/j.se-
marthrit.2015.11.009. PubMed.
Review article: Biomedical intelligence Swiss Med Wkly. 2021;151:w20465
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 6 of 8
34 McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of
painful osteoarthritis of the hands. J Rheumatol. 1992;19(4):604–7.
PubMed.
35 Laslett LL, Jones G. Capsaicin for osteoarthritis pain. Prog Drug Res.
2014;68:277–91. PubMed.
36 Gabay C, Medinger-Sadowski C, Gascon D, Kolo F, Finckh A. Sympto-
matic effects of chondroitin 4 and chondroitin 6 sulfate on hand os-
teoarthritis: a randomized, double-blind, placebo-controlled clinical trial
at a single center. Arthritis Rheum. 2011;63(11):3383–91. doi:
http://dx.doi.org/10.1002/art.30574. PubMed.
37 Reginster JY, Neuprez A, Lecart MP, Sarlet N, Bruyere O. Role of glu-
cosamine in the treatment for osteoarthritis. Rheumatol Int.
2012;32(10):2959–67. doi: http://dx.doi.org/10.1007/
s00296-012-2416-2. PubMed.
38 Rovetta GMP. Dexketoprofen-trometamol in patients with osteoarthritis
of the hands. Minerva Ortop Traumatol. 2001;52(1):27–30.
39 McKendry RTC, Weisman M. Hydroxychloroquine (HCQ) versus aceta-
minophen (ACM) versus placebo (PL) in the treatment of nodal os-
teoarthritis (NOA) of the hands. J Rheumatol. 2001;28:1421.
40 Fowler A, Swindells MG, Burke FD. Intra-articular corticosteroid injec-
tions to manage trapeziometacarpal osteoarthritis-a systematic review.
Hand (N Y). 2015;10(4):583–92. doi: http://dx.doi.org/10.1007/
s11552-015-9778-3. PubMed.
41 Swindells MG, Logan AJ, Armstrong DJ, Chan P, Burke FD, Lindau
TR. The benefit of radiologically-guided steroid injections for
trapeziometacarpal osteoarthritis. Ann R Coll Surg Engl.
2010;92(8):680–4. doi: http://dx.doi.org/10.1308/
003588410X12699663905078. PubMed.
42 Rocchi L, Merolli A, Giordani L, Albensi C, Foti C. Trapeziometacarpal
joint osteoarthritis: a prospective trial on two widespread conservative
therapies. Muscles Ligaments Tendons J. 2018;7(4):603–10. doi:
http://dx.doi.org/10.32098/mltj.04.2017.16. PubMed.
43 Day CS, Gelberman R, Patel AA, Vogt MT, Ditsios K, Boyer MI. Basal
joint osteoarthritis of the thumb: a prospective trial of steroid injection
and splinting. J Hand Surg Am. 2004;29(2):247–51. doi:
http://dx.doi.org/10.1016/j.jhsa.2003.12.002. PubMed.
44 Riley N, Vella-Baldacchino M, Thurley N, Hopewell S, Carr AJ, Dean
BJF. Injection therapy for base of thumb osteoarthritis: a systematic re-
view and meta-analysis. BMJ Open. 2019;9(9):e027507. doi:
http://dx.doi.org/10.1136/bmjopen-2018-027507. PubMed.
45 Herold C, Rennekampff HO, Groddeck R, Allert S. Autologous Fat
Transfer for Thumb Carpometacarpal Joint Osteoarthritis: A Prospective
Study. Plast Reconstr Surg. 2017;140(2):327–35. doi: http://dx.doi.org/
10.1097/PRS.0000000000003510. PubMed.
46 Baker RHJ, Al-Shukri J, Davis TRC. Evidence-Based Medicine: Thumb
Basal Joint Arthritis. Plast Reconstr Surg. 2017;139(1):256e–66e. doi:
http://dx.doi.org/10.1097/PRS.0000000000002858. PubMed.
47 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H,
Acevedo Arozena A, et al. Guidelines for the use and interpretation of
assays for monitoring autophagy (3rd edition). Autophagy.
2016;12(1):1–222. doi: http://dx.doi.org/10.1080/
15548627.2015.1100356. PubMed.
48 Zafonte B, Szabo RM. Evidence-based medicine in hand surgery: clini-
cal applications and future direction. Hand Clin. 2014;30(3):269–83, v.
doi: http://dx.doi.org/10.1016/j.hcl.2014.04.005. PubMed.
49 Vermeulen GM, Slijper H, Feitz R, Hovius SE, Moojen TM, Selles RW.
Surgical management of primary thumb carpometacarpal osteoarthritis:
a systematic review. J Hand Surg Am. 2011;36(1):157–69. doi:
http://dx.doi.org/10.1016/j.jhsa.2010.10.028. PubMed.
50 Raven EE, Kerkhoffs GM, Rutten S, Marsman AJ, Marti RK, Albers
GH. Long term results of surgical intervention for osteoarthritis of the
trapeziometacarpal joint : comparison of resection arthroplasty,
trapeziectomy with tendon interposition and trapezio-metacarpal
arthrodesis. Int Orthop. 2007;31(4):547–54. doi: http://dx.doi.org/
10.1007/s00264-006-0217-5. PubMed.
51 Huang K, Hollevoet N, Giddins G. Thumb carpometacarpal joint total
arthroplasty: a systematic review. J Hand Surg Eur Vol.
2015;40(4):338–50. doi: http://dx.doi.org/10.1177/1753193414563243.
PubMed.
52 Yuan BJ, Moran SL, Tay SC, Berger RA. Trapeziectomy and carpal col-
lapse. J Hand Surg Am. 2009;34(2):219–27. doi: http://dx.doi.org/
10.1016/j.jhsa.2008.11.007. PubMed.
53 Marks M, Hensler S, Wehrli M, Scheibler AG, Schindele S, Herren DB.
Trapeziectomy With Suspension-Interposition Arthroplasty for Thumb
Carpometacarpal Osteoarthritis: A Randomized Controlled Trial Com-
paring the Use of Allograft Versus Flexor Carpi Radialis Tendon. J Hand
Surg Am. 2017;42(12):978–86. doi: http://dx.doi.org/10.1016/j.jh-
sa.2017.07.023. PubMed.
54 Wajon A, Vinycomb T, Carr E, Edmunds I, Ada L. Surgery for thumb
(trapeziometacarpal joint) osteoarthritis. Cochrane Database Syst Rev.
2015;(2):CD004631. PubMed.
55 Yang Y, Tien HY, Kumar KK, Chen S, Li Z, Tian W, et al. Ligament re-
construction with tendon interposition arthroplasty for first car-
pometacarpal joint osteoarthritis. Chin Med J (Engl).
2014;127(22):3921–5. PubMed.
56 Yang SS, Weiland AJ. First metacarpal subsidence during pinch after
ligament reconstruction and tendon interposition basal joint arthroplasty
of the thumb. J Hand Surg Am. 1998;23(5):879–83. doi:
http://dx.doi.org/10.1016/S0363-5023(98)80167-6. PubMed.
57 Gangopadhyay S, McKenna H, Burke FD, Davis TR. Five- to 18-year
follow-up for treatment of trapeziometacarpal osteoarthritis: a prospec-
tive comparison of excision, tendon interposition, and ligament recon-
struction and tendon interposition. J Hand Surg Am. 2012;37(3):411–7.
doi: http://dx.doi.org/10.1016/j.jhsa.2011.11.027. PubMed.
58 Tay SC, Moran SL, Shin AY, Linscheid RL. The clinical implications of
scaphotrapezium-trapezoidal arthritis with associated carpal instability. J
Hand Surg Am. 2007;32(1):47–54. doi: http://dx.doi.org/10.1016/j.jh-
sa.2006.10.021. PubMed.
59 Ceruso M, Munz G, Carulli C, Virgili G, Viviani A, Hollevoet N, et al.
Thumb TMC Joint Osteo-Arthritis. In: Giddins G, Leblebicioğlu G
(eds). Evidence Based Data In Hand Surgery And Therapy. St Gallen:
FESSH; 2017. pp 368–428
60 Wachtl SW, Guggenheim PR, Sennwald GR. Cemented and non-ce-
mented replacements of the trapeziometacarpal joint. J Bone Joint Surg
Br. 1998;80-B(1):121–5. doi: http://dx.doi.org/10.1302/
0301-620X.80B1.0800121. PubMed.
61 van Cappelle HG, Elzenga P, van Horn JR. Long-term results and loos-
ening analysis of de la Caffinière replacements of the trapeziometacarpal
joint. J Hand Surg Am. 1999;24(3):476–82. doi: http://dx.doi.org/
10.1053/jhsu.1999.0476. PubMed.
62 Giddins G. Thumb arthroplasties. J Hand Surg Eur Vol.
2012;37(7):603–4. doi: http://dx.doi.org/10.1177/1753193412455988.
PubMed.
63 Degeorge B, Dagneaux L, Andrin J, Lazerges C, Coulet B, Chammas M.
Do trapeziometacarpal prosthesis provide better metacarpophalangeal
stability than trapeziectomy and ligamentoplasty? Orthop Traumatol
Surg Res. 2018;104(7):1095–100. doi: http://dx.doi.org/10.1016/j.ot-
sr.2018.07.008. PubMed.
64 Jager T, Barbary S, Dap F, Dautel G. Analyse de la douleur postopéra-
toire et des résultats fonctionnels précoces dans le traitement de la
rhizarthrose. Étude prospective comparative de 74 patientes trapézec-
tomie-interposition vs prothèse MAIA® [Evaluation of postoperative
pain and early functional results in the treatment of carpometacarpal
joint arthritis. Comparative prospective study of trapeziectomy vs. MA-
IA(®) prosthesis in 74 female patients]. Chir Main. 2013;32(2):55–62.
Article in French. doi: http://dx.doi.org/10.1016/j.main.2013.02.004.
PubMed.
65 Jurča J, Němejc M, Havlas V. [Surgical Treatment for Advanced
Rhizarthrosis. Comparison of Results of the Burton-Pellegrini Tech-
nique and Trapeziometacarpal Joint Arthroplasty]. Acta Chir Orthop
Traumatol Cech. 2016;83(1):27–31. Article in Czech. PubMed.
66 Vandenberghe L, Degreef I, Didden K, Fiews S, De Smet L. Long term
outcome of trapeziectomy with ligament reconstruction/tendon interpo-
sition versus thumb basal joint prosthesis. J Hand Surg Eur Vol.
2013;38(8):839–43. doi: http://dx.doi.org/10.1177/1753193412469010.
PubMed.
67 Cebrian-Gomez R, Lizaur-Utrilla A, Sebastia-Forcada E, Lopez-Prats
FA. Outcomes of cementless joint prosthesis versus tendon interposition
for trapeziometacarpal osteoarthritis: a prospective study. J Hand Surg
Eur Vol. 2019;44(2):151–8. doi: http://dx.doi.org/10.1177/
1753193418787151. PubMed.
68 Tchurukdichian A, Guillier D, Moris V, See LA, Macheboeuf Y. Results
of 110 IVORY® prostheses for trapeziometacarpal osteoarthritis with a
minimum follow-up of 10 years. J Hand Surg Eur Vol.
2020;45(5):458–64. doi: http://dx.doi.org/10.1177/1753193419899843.
PubMed.
69 Froschauer SM, Holzbauer M, Hager D, Schnelzer R, Kwasny O,
Duscher D. Elektra prosthesis versus resection-suspension arthroplasty
for thumb carpometacarpal osteoarthritis: a long-term cohort study. J
Hand Surg Eur Vol. 2020;45(5):452–7. doi: http://dx.doi.org/10.1177/
1753193419873230. PubMed.
70 Froschauer SM, Holzbauer M, Schnelzer RF, Behawy M, Kwasny O,
Aitzetmüller MM, et al. Total arthroplasty with Ivory® prosthesis versus
resection-suspension arthroplasty: a retrospective cohort study on 82
carpometacarpal-I osteoarthritis patients over 4 years. Eur J Med Res.
2020;25(1):13. doi: http://dx.doi.org/10.1186/s40001-020-00411-8.
PubMed.
Review article: Biomedical intelligence Swiss Med Wkly. 2021;151:w20465
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 7 of 8
71 Lussiez B, Ledoux P, Falaise C. Prothèse trapèze-métacarpienne à dou-
ble mobilité: revue d’une série de 132 cas à plus de 1 an de recul [Dual-
mobility trapezio-metacarpal prosthesis: Report of 132 first cases with a
minimum follow-up of 1 year]. Revue de Chirurgie Orthopédique et
Traumatologique. 2017;103(7):S61. Article in French. doi:
http://dx.doi.org/10.1016/j.rcot.2017.09.092.
72 Remy S, Detrembleur C, Libouton X, Bonnelance M, Barbier O.
Trapeziometacarpal prosthesis: an updated systematic review. Hand
Surg Rehabil. 2020;39(6):492–501. doi: http://dx.doi.org/10.1016/
j.hansur.2020.08.005. PubMed.
73 Russo S, Bernasconi A, Busco G, Sadile F. Treatment of the
trapeziometacarpal osteoarthritis by arthroplasty with a pyrocarbon im-
plant. Int Orthop. 2016;40(7):1465–71. doi: http://dx.doi.org/10.1007/
s00264-015-3016-z. PubMed.
74 Barrera-Ochoa S, Vidal-Tarrason N, Correa-Vázquez E, Reverte-Vinaixa
MM, Font-Segura J, Mir-Bullo X. Pyrocarbon interposition (PyroDisk)
implant for trapeziometacarpal osteoarthritis: minimum 5-year follow-
up. J Hand Surg Am. 2014;39(11):2150–60. doi: http://dx.doi.org/
10.1016/j.jhsa.2014.07.011. PubMed.
75 Erne HC, Schmauß D, Cerny M, Schmauss V, Ehrl D, Löw S, et al. Re-
sektionsarthroplastik nach Lundborg vs. Pyrocarbon-Spacer (Pyrocar-
dan®) bei fortgeschrittener Rhizarthrose – Eine Zwei-Center-Studie
[Lundborg’s resection arthroplasty vs. Pyrocarbon spacer (Pyrocardan®)
for the treatment of trapeziometacarpal joint osteoarthritis: a two-centre
study]. Handchir Mikrochir Plast Chir. 2017;49(3):175–80. Article in
German. dio:. http://dx.doi.org/10.1055/s-0043-115220. PubMed.
76 Oh WT, Chun YM, Koh IH, Shin JK, Choi YR, Kang HJ. Tendon versus
Pyrocarbon Interpositional Arthroplasty in the Treatment of
Trapeziometacarpal Osteoarthritis. BioMed Res Int.
2019;2019:7961507. doi: http://dx.doi.org/10.1155/2019/7961507.
PubMed.
77 Gerace E, Royaux D, Gaisne E, Ardouin L, Bellemère P. Pyrocardan®
implant arthroplasty for trapeziometacarpal osteoarthritis with a mini-
mum follow-up of 5 years. Hand Surg Rehabil. 2020;39(6):528–38. doi:
http://dx.doi.org/10.1016/j.hansur.2020.09.003. PubMed.
78 Odella S, Querenghi AM, Sartore R, DE Felice A, Dacatra U.
Trapeziometacarpal osteoarthritis: pyrocarbon interposition implants.
Joints. 2015;2(4):154–8. PubMed.
79 Lauwers TM, Brouwers K, Staal H, Hoekstra LT, van der Hulst RR.
Early outcomes of Pyrocardan® implants for trapeziometacarpal os-
teoarthritis. Hand Surg Rehabil. 2016;35(6):407–12. doi:
http://dx.doi.org/10.1016/j.hansur.2016.09.004. PubMed.
80 Gauthier E, Truffandier MV, Gaisne E, Bellemère P. Treatment of
scaphotrapeziotrapezoid osteoarthritis with the Pyrocardan® implant:
Results with a minimum follow-up of 2 years. Hand Surg Rehabil.
2017;36(2):113–21. doi: http://dx.doi.org/10.1016/j.hansur.2017.01.003.
PubMed.
81 De Smet L, Van Meir N, Verhoeven N, Degreef I. Is there still a place
for arthrodesis in the surgical treatment of basal joint osteoarthritis of
the thumb? Acta Orthop Belg. 2010;76(6):719–24. PubMed.
82 Rizzo M, Moran SL, Shin AY. Long-term outcomes of
trapeziometacarpal arthrodesis in the management of trapeziometacarpal
arthritis. J Hand Surg Am. 2009;34(1):20–6. doi: http://dx.doi.org/
10.1016/j.jhsa.2008.09.022. PubMed.
83 Hartigan BJ, Stern PJ, Kiefhaber TR. Thumb carpometacarpal os-
teoarthritis: arthrodesis compared with ligament reconstruction and ten-
don interposition. J Bone Joint Surg Am. 2001;83(10):1470–8. doi:
http://dx.doi.org/10.2106/00004623-200110000-00002. PubMed.
84 Taylor EJ, Desari K, D’Arcy JC, Bonnici AV. A comparison of fusion,
trapeziectomy and silastic replacement for the treatment of osteoarthritis
of the trapeziometacarpal joint. J Hand Surg [Br]. 2005;30(1):45–9. doi:
http://dx.doi.org/10.1016/J.JHSB.2004.08.006. PubMed.
Review article: Biomedical intelligence Swiss Med Wkly. 2021;151:w20465
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 8 of 8
